Literature DB >> 18698527

Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners.

L F Moller1, B J van den Bergh, S Karymbaeva, A Esenamanova, R Muratalieva.   

Abstract

In Kyrgyzstan the prevalence of injecting drug behaviour is among the highest found throughout the world. Health promotion training, improved health care and needle/syringe exchange (NSE) programmes have been shown to decrease risk behaviour among injecting drug users. In Kyrgyzstan, an intervention study with training of prison staff and prisoners was performed in one prison. Before and after the training, a random selection of the prisoners answered a questionnaire about drug use, risk behaviour and health care. The survey was carried out in both the intervention prison and in a reference prison. The number of drug users, the use of drugs and risk behaviour were improved significantly within half a year and, especially, the injection and use of drugs decreased in the intervention group. The study clearly shows that increased focus, improved healthcare and training of prisoners and staff on drug use and harm reduction can reduce both use of drugs and risk behaviour.

Mesh:

Year:  2008        PMID: 18698527     DOI: 10.1080/17449200802264654

Source DB:  PubMed          Journal:  Int J Prison Health        ISSN: 1744-9200


  3 in total

1.  Managing drugs in the prisoner society: heroin and social order in Kyrgyzstan's prisons.

Authors:  Gavin Slade; Lyuba Azbel
Journal:  Punishm Soc       Date:  2020-09-23

2.  "My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan.

Authors:  Doris Burtscher; Rafael Van den Bergh; Ulan Toktosunov; Nilza Angmo; Nazgul Samieva; Eva P Rocillo Arechaga
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

3.  Substance Use During Imprisonment in Low- and Middle-Income Countries.

Authors:  Adrian P Mundt; Gergo Baranyi; Caroline Gabrysch; Seena Fazel
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.